Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2Sexuality 1Sexual Dysfunction, Physiological 1Radiation Injuries 1Multiple Endocrine Neoplasia Type 1 1Erectile Dysfunction 1

Interventions

Radiotherapy 4Cisplatin 4Radiotherapy, Intensity-Modulated 2Radiosurgery 2Paclitaxel 2Donepezil 2Carboplatin 2Bevacizumab 2Amifostine 2sargramostim 1ethanethiol 1Vincristine 1Surgical Procedures, Operative 1Selenomethionine 1Salts 1Rituximab 1Radiation 1Procarbazine 1Oral Hygiene 1Neck Dissection 1Mometasone Furoate 1Methylprednisolone 1Methotrexate 1Magnetic Resonance Spectroscopy 1Lovastatin 1Fluorouracil 1Fibroblast Growth Factor 7 1Drug Therapy 1Cytarabine 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Radiation Injuries × Arginine × Clear all
NCT01105130 2021-09-28

L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors

Wake Forest University Health Sciences

Phase 2 Completed
140 enrolled 13 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡